Value Over Price: What Lonza, Kavis Pharma, and Ansell Gloves Taught Me About Procurement
Honestly, I didn't start out as a procurement expert. Nine years ago, I was the person who compared quotes and picked the lowest one. Today, I maintain our team's pre-order checklist. In between, I've made and documented 12 significant buying mistakes. They cost roughly $180,000 in wasted budget. And almost every one of them came from the same bad logic: "the other option is cheaper, so I should take it."
Here's my view, and I don't hedge on it: In pharma and life science procurement, value has to beat price. If you choose based only on sticker price, you're not saving money—you're buying risk.
The Lonza order that broke my "cheapest quote" habit
In my second year, I needed cell culture media for a production run. I had a quote from a distributor that was 18% below the GMP-grade option from Lonza. I went back and forth for almost a week. The distributor said the catalog number matched. The volume was the same. It looked like the same product.
It wasn't. The order arrived two days late. The certificate of analysis had the wrong lot number. Our quality team rejected the whole delivery. We had to reorder the Lonza product through the Lonza shop, this time with rush shipping. The result was a 6-day delay and about $2,800 in extra cost. The amount I had saved on the original quote: $320.
I still kick myself. If I had used total cost instead of unit price, I'd have seen that $2,800 delay coming. Today, when I use Lonza login, I don't just add to cart. I verify the grade, the COA, the lot number, and the delivery date before I approve anything.
The Lonza shop isn't the problem. It's actually pretty easy to use. The problem is that buyers like me try to skip the verification step to save a bit of money.
New pharma teams can't afford to skip the same step
I've watched the same thing happen in new pharma companies. Budgets are tight. Timelines are aggressive. Someone says, "Why are we paying GMP prices? Can't we use a cheaper chemical supplier?" And that's how the next round of expensive mistakes starts.
I remember a conversation with a quality director at Kavis Pharma during a supplier qualification review. He told me the documentation review is the order. The material is easy to buy; the compliance trail is the hard part. Kavis Pharma, like any pharma company, still has to follow GMP rules. A cheaper quote does not change that requirement.
If you're a new pharma team, treat the qualification step as part of the purchase. The company you validate today is the company you'll depend on when production starts. That's worth more than a 15% discount.
Can Ansell chemical resistant gloves handle hydrochloric acid?
A few years ago, someone asked me, "Can Ansell chemical resistant gloves handle hydrochloric acid?" It sounds like a yes/no question. I treated it like one, and I ordered a crate of the cheapest chemical resistant gloves I could find.
They could handle some chemicals. They were not rated for concentrated hydrochloric acid. We caught the problem during a safety audit, not during a spill. Our team replaced every pair with gloves matched to the actual chemical concentration. The cost of the replacement was higher than the price of the correct gloves would have been on day one.
So let me answer the question properly: Ansell makes chemical resistant gloves that can handle hydrochloric acid, but only if you choose the model tested for that chemical, concentration, and exposure time. You need to check the permeation data in the Ansell Chemical Resistance Guide or the test results under methods like EN 374 or ASTM F739. The brand name alone isn't the answer. And the price per box definitely isn't.
What I mean when I say value over price
I'm not arguing for buying the most expensive option every time. I'm arguing that you should compare total cost, not sticker price.
Here's the total cost list I use now:
- Purchase price - what's on the PO.
- Qualification cost - time spent checking the supplier, the product, the COA, and the release testing.
- Documentation cost - making sure lot numbers, expiry dates, shipping conditions, and batch records all fit the process.
- Failure risk - what happens if the material is rejected.
- Downtime cost - every day of production delay caused by a bad order.
Using that checklist, our team caught 47 potential order errors in 18 months. Some were small. Others would have caused rejected batches. I can't tell you exactly how much money that saved, but I know it's more than the $180,000 I lost before I built it.
But what if the budget really is tight?
I know what you're thinking. Your CFO doesn't fund "total cost." Your budget is a number, and someone will compare your PO price to another supplier's quote. I get it.
So let me be clear: value over price doesn't mean ignore price. It means making price one input, not the only input. In practice, I've approved the lowest quote many times. But I only do it after I can verify the other requirements in writing.
If a supplier can't provide the right documentation or won't guarantee the delivery date, their "cheaper" price is actually an incomplete price. The missing verification will show up later—as extra cost, extra work, or extra risk.
A simple rule for the next PO
My rule now is simple:
Never let the unit price make a decision that the quality, compliance, and safety data should make.
That's why I start with suppliers I can trace and verify, whether that's a Lonza shop order or a direct conversation with a manufacturing site. That's why I ask the same documentation questions to a new pharma vendor as I would to Kavis Pharma or any established CDMO. And that's why I now check chemical resistance tables before I order gloves—even when the question sounds as simple as "Can Ansell chemical resistant gloves handle hydrochloric acid?"
The price tag is what you pay. The cost is what happens after you pay it. If you choose based on value, you'll catch the problems early. If you choose based on price alone, you'll catch them later. I've done both. I can tell you which one is cheaper.
Download our 2025 integrated report
For more context on sustainability, quality, and operational governance, request the latest report package from Lonza.